Guardant Health partners with Quest for blood-based cancer screening
Go back to Guardant Health partners with Quest for blood-based cancer screening| Quest Diagnostics (NYSE: DGX) | Delayed: 199.21 -4.77 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $203.98 | 52 Week High | $86.85 | |||
| Open | $203.76 | 52 Week Low | $59.66 | |||
| Day High | $203.78 | P/E | 37.52 | |||
| Day Low | $199.01 | EPS | $5.31 | |||
| Volume | 1,055,721 | |||||
| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 91.20 -1.38 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.58 | 52 Week High | $5.84 | |||
| Open | $90.01 | 52 Week Low | $5.49 | |||
| Day High | $93.00 | P/E | N/A | |||
| Day Low | $89.00 | EPS | $0.00 | |||
| Volume | 1,272,484 | |||||
